{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:08:28Z","timestamp":1791306508059,"version":"4.3.1"},"reference-count":16,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl J Gynecology &amp; Obste"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study compares recommendations from international clinical guidelines regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of non\u2010invasive prenatal testing (NIPT), invasive diagnostic procedures, and advanced genomic technologies. An integrative review was conducted in guidelines and consensus statements from international societies to compare recommendations regarding prenatal screening and diagnostic testing for fetal genetic abnormalities, including the role of NIPT, invasive diagnostic procedures, and advanced genomic technologies. A systematic search was conducted in PubMed, Scopus, the Cochrane Library, and EMBASE for guidelines published up to December 2025. Guidelines from major obstetrics and genetics societies were included. Findings were synthesized and compared qualitatively across guidelines. Nine international guidelines were included in the analysis. Most societies recommend offering prenatal screening for aneuploidy to all pregnant women. NIPT was consistently described as the most sensitive screening method for common aneuploidies, although not recommended as a diagnostic test. Invasive procedures, including amniocentesis and chorionic villus sampling, remain the gold standard for diagnostic confirmation. Recommendations regarding advanced genomic testing varied, with chromosomal microarray generally recommended in cases of fetal structural anomalies, while routine prenatal exome sequencing remains limited to selected scenarios. Although international guidelines show broad agreement regarding the importance of prenatal screening and confirmatory diagnostic testing, differences persist in the implementation of screening strategies and the integration of emerging genomic technologies.<\/jats:p>","DOI":"10.1002\/ijgo.71259","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:16:18Z","timestamp":1786173378000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal screening and diagnostic strategies for fetal genetic abnormalities: Comparison of international clinical guidelines"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7322-2157","authenticated-orcid":false,"given":"Geovanna Saboia","family":"Veras","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology The State University of Campinas  Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-0720","authenticated-orcid":false,"given":"Jo\u00e3o Renato","family":"Bennini","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology The State University of Campinas  Campinas SP Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.08.040"},{"issue":"2","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijgo.16068","article-title":"Prenatal multidisciplinary counseling for fetal congenital anomalies: a narrative review","volume":"169","author":"Lugli L","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0000000000000267","article-title":"The case for universal prenatal genetic counseling","volume":"123","author":"Minkoff H","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2015.11.006","article-title":"Screening for fetal aneuploidy","volume":"40","author":"Rink BD","year":"2016","journal-title":"Semin Perinatol"},{"issue":"11","key":"e_1_2_11_6_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2024.102694","article-title":"Guideline No. 456: prenatal screening for fetal chromosomal anomalies","volume":"46","author":"Audibert F","year":"2024","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2648.2005.03621.x","article-title":"The integrative review: updated methodology","volume":"52","author":"Whittemore R","year":"2005","journal-title":"J Adv Nurs"},{"issue":"1","key":"e_1_2_11_8_1","first-page":"102","article-title":"Revis\u00e3o integrativa: o que \u00e9 e como fazer","volume":"8","author":"Souza MT","year":"2010","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","DOI":"10.1002\/pmf2.70139","article-title":"Society for maternal\u2010fetal medicine consult series #74: cell\u2010free DNA screening for aneuploidies: updated guidance","volume":"1","author":"Society for Maternal\u2010Fetal Medicine (SMFM)","year":"2025","journal-title":"Pregnancy"},{"key":"e_1_2_11_11_1","volume-title":"NHS Fetal Anomaly Screening Programme (FASP): Programme Overview [Internet]","author":"NHS England","year":"2013"},{"issue":"10","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/jmedgenet-2021-107897","article-title":"Clinical application of fetal genome\u2010wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists","volume":"59","author":"Lazier J","year":"2022","journal-title":"J Med Genet"},{"issue":"4","key":"e_1_2_11_13_1","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e27","article-title":"Clinical practice guidelines for prenatal aneuploidy screening and diagnostic testing from Korean Society of Maternal\u2010Fetal Medicine: (1) prenatal aneuploidy screening","volume":"36","author":"Choe SA","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"4","key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jmedgenet-2017-105013","article-title":"Practice guideline: joint CCMG\u2010SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada","volume":"55","author":"Armour CM","year":"2018","journal-title":"J Med Genet"},{"issue":"6","key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/uog.17483","article-title":"ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice","volume":"49","author":"Salomon LJ","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226","volume":"136","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics; Committee on Genetics; Society for Maternal\u2010Fetal Medicine","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1097\/AOG.0000000000001817","article-title":"Microarrays and next\u2010generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology","volume":"128","author":"Committee Opinion No.682","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.71259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijgo.71259","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijgo.71259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:16:21Z","timestamp":1786173381000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/ijgo.71259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":16,"alternative-id":["10.1002\/ijgo.71259"],"URL":"https:\/\/doi.org\/10.1002\/ijgo.71259","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"2026-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ijgo.71259"}}